Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Boehringer Ingelheim files for regulatory approval of nintedanib

pharmaceutical-technologyMarch 20, 2019

Tag: Boehringer Ingelheim , EMA , idiopathic pulmonary fibrosis , nintedanib

PharmaSources Customer Service